Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

BOSTON (February 22, 2023) – Saul Ewing LLP today announced that Partner Joseph D. Lipchitz has been named Managing Partner of the firm’s Boston office. The Managing Partner is responsible for the office’s budget, internal communications and events, in addition to overseeing the firm’s involvement...